Table 2.

Characteristics of patients suffering from PD with sialorrhea

N	14
Gender (F/M)	3/11
Age (years)	70.00±9.82 (56–87)
The duration of BoNT-A treatment (months)	18.78±10.37 (10–45)
The dose of BoNT-A (units)	34.35±6.41 (25–45)
Number of injections (n, %)
2	6 (42.8)
3	7 (50.0)
4	1 (7.2)
The response latency (days)	4.50±1.09 (3–7)
The peak improvement time (days)	12.92±2.16 (7–15)
The duration of efficacy (weeks)	17.67±9.09 (12.5–48)
The application interval (months)	5.82±2.75 (4–13)
The experienced improvement of sialorrhea (%)	71.78±12.95 (50–90)

Data are presented as mean±standard deviation (range), BoNT-A: Botulinum toxin type A; PD: Parkinson’s disease